NEWS SOURCE: Reaction Biology Corporation
MALVERN, PA (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (“RBC”) today announced that it has been awarded an R01 grant from the National Institutes of Health to accelerate development of its new DiscoveryDot(TM) High Throughput Screening technology for drug discovery. The NIH grant is part of the Screening Roadmap, designed to produce innovative chemical tools for use in biological research and drug development. Out of 8 recipients of grants pursuant to the original RFA, Reaction Biology is the only private corporation to be so awarded.
The grant provides for $1,828,000 in funding over four years. It originates from the National Human Genome Research Institute and funds two specific areas: 1) The further development of RBC’s proprietary spray deposition technology for High Throughput Screening (“HTS”) reaction activation, and 2) The development of enhanced microarray printing technology for use in RBC’s DiscoveryDot(TM) HTS system and elsewhere.
The DiscoveryDot(TM) technology currently is capable of screening up to 6,600 individual reactions at 1 nanoliter volume on a 1-by-3 inch glass slide. Millions of dollars can be saved on large scale screening campaigns through reagent savings, process costs, and labor reduction. RBC intends to further increase the throughput of its HTS process through the development of enhanced microarray printing and automated spray deposition.
About Reaction Biology Corporation
Reaction Biology, based in Malvern, Pa., provides high throughput screening services to the biotechnology and pharmaceutical industries. The company uses a patent-pending combination of technologies to perform screening at the nanoliter scale, while preserving quality, speed and simplicity.
Combining genomics microarray printing technology and picoliter aerosol deposition, RBC has commercialized a novel technology that drives HTS to new levels of simplicity and efficiency.
More information: http://www.reactionbiology.com
Reaction Biology Corporation, 1764 Litchfield Turnpike, Suite 203 * Woodbridge, CT 06525 * 203-389-7407.
News issued by: Reaction Biology Corporation
# # #
Original Story ID: (1421) :: 2006-03-0313-005
Original Keywords: National Institutes of Health, development of High Throughput Screening technology for drug discovery, Reaction Biology Corp, DiscoveryDot, HTS system, RBC, Malvern, Pennsylvania, genomics microarray printing technology and picoliter aerosol deposition, Screening Roadmap, designed to produce innovative chemical tools Reaction Biology Corporation
NEWS SOURCE: Reaction Biology Corporation | Published: 2006-03-13 21:06:00
IMPORTANT NOTICE FOR ARCHIVAL CONTENT ABOVE: The above archival press release content was issued on behalf of the noted "news source" who provided the content (text and image[s]) and is solely responsible for its accuracy. Links may not work if very old; use such with caution. Send2Press does not represent the "news source" in any capacity. For questions about this content contact the company/person mentioned directly. To report fraud or illegal material, or DMCA complaints, please contact Send2Press via our main site (any such complaints must be made in writing, not by phone).
